C. Andréjak
Impact in
- Small Animals top 5%
- Infectious Diseases and Mycology
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
Papers in
- Epidemiology 14
- Mycobacterium research and diagnosis 13
-
- Tuberculosis Research and Epidemiology 6
- COVID-19 Clinical Research Studies 2
- Co-authors
- V. Jounieaux (10 shared papers)Damien Basille (5 shared papers)J Grosset (2 shared papers)Sandeep Tyagi (2 shared papers)Y. Douadi (2 shared papers)G. Laurans (2 shared papers)Deepak V. Almeida (2 shared papers)Nicole C. Ammerman (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)Pharmaceuticals (2 papers)Life (1 paper)Thorax (1 paper)PLoS ONE (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
C. Andréjak
24 papers receiving 361 citations
Peers
Comparison fields: 5 of 61
- Small Animals 60
- Infectious Diseases 122
- Epidemiology 194
- Microbiology 2
- Critical Care and Intensive Care Medicine 10
Countries citing papers authored by C. Andréjak
This map shows the geographic impact of C. Andréjak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Andréjak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Andréjak more than expected).
Fields of papers citing papers by C. Andréjak
This network shows the impact of papers produced by C. Andréjak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Andréjak. The network helps show where C. Andréjak may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Andréjak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 67 | |
| 2 | 2011 | 46 | |
| 3 | 2015 | 40 | |
| 4 | 2016 | 37 | |
| 5 | 2020 | 27 | |
| 6 | 2017 | 20 | |
| 7 | 2020 | 19 | |
| 8 | 2012 | 18 | |
| 9 | 2007 | 17 | |
| 10 | 2018 | 17 | |
| 11 | 2021 | 14 | |
| 12 | 2020 | 12 | |
| 13 | 2021 | 8 | |
| 14 | 2015 | 7 | |
| 15 | 2019 | 4 | |
| 16 | 2011 | 4 | |
| 17 | 2009 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2022 | 1 | |
| 20 | 2016 | 1 |
About C. Andréjak
C. Andréjak is a scholar working on Epidemiology, Infectious Diseases, Organic Chemistry, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 28 papers that have together received 370 indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (13 papers), Tuberculosis Research and Epidemiology (6 papers), Quinazolinone synthesis and applications (5 papers), COVID-19 Clinical Research Studies (2 papers), Vascular Anomalies and Treatments (2 papers), Respiratory Support and Mechanisms (1 paper), Cancer therapeutics and mechanisms (1 paper) and Pleural and Pulmonary Diseases (1 paper). The work is most often cited by research in Small Animals (60 citations), Infectious Diseases (122 citations), Epidemiology (194 citations), Microbiology (2 citations) and Critical Care and Intensive Care Medicine (10 citations). C. Andréjak has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include V. Jounieaux, Damien Basille, J Grosset, Sandeep Tyagi, Y. Douadi, G. Laurans, Deepak V. Almeida, Nicole C. Ammerman, Paul J. Converse and P. Duhaut. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Pharmaceuticals, Life, Thorax and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.